Takayoshi Hirota

1.1k total citations
54 papers, 858 citations indexed

About

Takayoshi Hirota is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Takayoshi Hirota has authored 54 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Takayoshi Hirota's work include Cardiomyopathy and Myosin Studies (34 papers), Cardiovascular Effects of Exercise (14 papers) and Cardiovascular Function and Risk Factors (12 papers). Takayoshi Hirota is often cited by papers focused on Cardiomyopathy and Myosin Studies (34 papers), Cardiovascular Effects of Exercise (14 papers) and Cardiovascular Function and Risk Factors (12 papers). Takayoshi Hirota collaborates with scholars based in Japan and United States. Takayoshi Hirota's co-authors include Hiroaki Kitaoka, Toru Kubo, Naohito Yamasaki, Yoshinori Doi, Yuichi Baba, Yoshihisa Matsumura, Makoto Okawa, Kayo Hayato, Toshikazu Yabe and Shigeo Yamanaka and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Takayoshi Hirota

50 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takayoshi Hirota Japan 16 687 184 138 79 76 54 858
Marta Rubino Italy 16 494 0.7× 210 1.1× 152 1.1× 92 1.2× 121 1.6× 65 727
Adelaide Fusco Italy 13 265 0.4× 123 0.7× 90 0.7× 58 0.7× 47 0.6× 40 398
Jean-Pierre Gueffet France 6 221 0.3× 238 1.3× 90 0.7× 118 1.5× 26 0.3× 9 478
Mohammed Rabiul Hosen Germany 11 283 0.4× 426 2.3× 73 0.5× 82 1.0× 39 0.5× 21 769
António Nunes Diogo Portugal 9 171 0.2× 165 0.9× 36 0.3× 47 0.6× 26 0.3× 30 371
Yaron Fridman United States 10 347 0.5× 206 1.1× 29 0.2× 68 0.9× 48 0.6× 12 591
Virginia Álvarez Spain 17 241 0.4× 130 0.7× 64 0.5× 129 1.6× 35 0.5× 41 505
Olga Azevedo Portugal 13 185 0.3× 114 0.6× 120 0.9× 52 0.7× 256 3.4× 64 494
Alessandra Serio Italy 16 1.0k 1.5× 171 0.9× 131 0.9× 142 1.8× 38 0.5× 34 1.2k
Bingyuan Wu China 13 143 0.2× 184 1.0× 58 0.4× 84 1.1× 17 0.2× 29 435

Countries citing papers authored by Takayoshi Hirota

Since Specialization
Citations

This map shows the geographic impact of Takayoshi Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayoshi Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayoshi Hirota more than expected).

Fields of papers citing papers by Takayoshi Hirota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayoshi Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayoshi Hirota. The network helps show where Takayoshi Hirota may publish in the future.

Co-authorship network of co-authors of Takayoshi Hirota

This figure shows the co-authorship network connecting the top 25 collaborators of Takayoshi Hirota. A scholar is included among the top collaborators of Takayoshi Hirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayoshi Hirota. Takayoshi Hirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamasaki, Naohito, Toru Kubo, Yuichi Baba, et al.. (2024). Importance of Fourth Heart Sound and Preserved Left Atrial Function in Wild-Type Transthyretin Amyloidosis. ESC Heart Failure. 11(6). 4000–4008. 3 indexed citations
2.
Baba, Yuichi, Toru Kubo, Takayoshi Hirota, et al.. (2023). High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement. Internal Medicine. 62(21). 3097–3105. 2 indexed citations
3.
Kubo, Toru, Yuichi Baba, Kazuya Miyagawa, et al.. (2023). Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy. Journal of Cardiology. 83(6). 359–364.
4.
Baba, Yuichi, et al.. (2022). A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries. JACC Case Reports. 4(14). 844–846. 3 indexed citations
6.
Kubo, Toru, et al.. (2020). Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I. Molecular Genetics and Metabolism Reports. 25. 100662–100662. 6 indexed citations
7.
Yamasaki, Naohito, et al.. (2020). A single atrial septal defect masquerading as multiple defects due to a refraction artifact – A cautionary note. Journal of Cardiology Cases. 22(2). 55–58. 1 indexed citations
8.
Kubo, Toru, Yuichi Baba, Takayoshi Hirota, et al.. (2020). Elevation of High-Sensitivity Cardiac Troponin T and Left Ventricular Remodelling in Hypertrophic Cardiomyopathy. ESC Heart Failure. 7(6). 3593–3600. 15 indexed citations
11.
Kubo, Toru, Yuichi Baba, Takayoshi Hirota, et al.. (2019). Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy. Journal of Cardiology. 75(1). 12–19. 15 indexed citations
12.
Baba, Yuichi, Toru Kubo, Shigeo Yamanaka, et al.. (2019). Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients. Journal of Cardiology. 74(6). 507–511. 11 indexed citations
13.
Kubo, Toru, et al.. (2017). Abstract 12143: A Validation Study of Phenotype-guided Genetic Testing Using the Mayo HCM Genotype Predictor Score for Japanese Patients With Hypertrophic Cardiomyopathy. Circulation. 1 indexed citations
14.
Kubo, Toru, et al.. (2016). An Abnormal Serum Concentration of High-sensitivity Cardiac Troponin T is Associated with Progression of Left Ventricular Remodeling in Hypertrophic Cardiomyopathy. Circulation. 80. 168. 5 indexed citations
15.
Kubo, Toru, Yuichi Baba, Takayoshi Hirota, et al.. (2016). Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. Journal of Cardiology. 69(1). 302–307. 27 indexed citations
16.
Kubo, Toru, Toshika Okumiya, Yuichi Baba, et al.. (2015). Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Journal of Cardiology. 67(3). 274–278. 11 indexed citations
17.
Kubo, Toru, Hiroaki Kitaoka, Shigeo Yamanaka, et al.. (2013). Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 62(14). 1252–1259. 114 indexed citations
18.
Hitomi, Nobuhiko, Toru Kubo, Hiroaki Kitaoka, et al.. (2010). A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. Journal of Cardiology. 56(2). 189–196. 13 indexed citations
19.
Kitaoka, Hiroaki, Toru Kubo, Makoto Okawa, et al.. (2009). Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: Comparison with B-type natriuretic peptide. Journal of Cardiology. 53(3). 361–367. 16 indexed citations
20.
Kubo, Toru, Yoshihisa Matsumura, Hiroaki Kitaoka, et al.. (2008). Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years. Journal of Cardiology. 52(2). 111–117. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026